Corporate Report on Saratoga Investment Corp.
Saratoga Investment Corp. (ticker SAR) recorded a decline of 4.63 % during the 24‑hour trading window that closed at 09:36 PM Central Europe on Wednesday, 21 October 2026. At the time of writing, a single share is available on major exchanges for approximately USD 13.60. The company’s current free‑float supply stands at 15.6 million shares, giving it a market capitalisation of USD 231.8 million. In the preceding 24 hours, roughly USD 1.8 million worth of shares changed hands.
The broader technical picture shows that SAR has been in a downtrend since the end of September, having fallen 19.12 % over the past month. The 200‑day simple moving average (SMA) sits at USD 20.91, well above today’s trading level. Historically, the stock’s 52‑week high was USD 24.07 on 2 March 2026, while the low reached USD 13.78 on 10 July 2026.
Upcoming Shareholder Meeting
Saratoga Investment Corp. has announced that its annual general meeting (AGM) will take place in November 2026. The company has outlined several resolutions that shareholders will be asked to approve:
- Remuneration Report – Adoption of the proposed remuneration framework for the upcoming fiscal year.
- Re‑Election of Director Paul Stenson – Confirmation of his continued service on the board.
- Share‑Based Remuneration – Approval of share‑based remuneration arrangements for several directors, replacing cash fees in accordance with ASX listing requirements.
- Share Appreciation Rights – Grant of share appreciation rights to related parties, including William Blackburn and Randall Lane.
- 7.1A Mandate – Authorization of a 7.1A mandate that would increase the company’s equity‑issue capacity, thereby enhancing capital‑raising flexibility while maintaining compliance with ASX rules.
These proposals aim to align executive incentives with shareholder interests and to provide the company with greater flexibility in raising capital.
Peer Performance in the Last 24 Hours
| Company | Ticker | % Change | Current Price (USD) | Market Capitalisation (USD) | P/E Ratio |
|---|---|---|---|---|---|
| Usana Health Sciences | USNA | –1.14 % | 14.16 | 275.1 million | – |
| Horizon Finance C | HTFB | 0 % | 4.06 | 275.5 million | 40.71 |
| Horizon Finance C | HRZN | –0.24 % | 4.10 | 275.5 million | 40.71 |
| Isabella Bank | ISBA | +2.65 % | 36.72 | 276.7 million | – |
| National Bankshares /Va | NKSH | +0.73 % | 43.90 | 278.1 million | 13.67 |
Isabella Bank’s modest rise coincides with a recent Form 4 filing, where director Jill Bourland disclosed the purchase of 5,933 additional shares on 16 October 2026. The transaction was made through a standard purchase and does not represent a material shift in the bank’s capital structure.
Business Overview
Saratoga Investment Corp. operates as a business development company that focuses on delivering financial services to lower‑end middle‑market enterprises. Its product suite includes leveraged and management buy‑outs, acquisition financings, growth financings, recapitalization strategies, debt refinancing, and transitional financing solutions.
Key Takeaways
- Short‑term decline: SAR’s share price has slipped by nearly 5 % in the most recent 24‑hour session, falling below its 200‑day SMA.
- Capital‑raising strategy: The AGM agenda includes measures designed to enhance executive alignment and improve the company’s ability to issue new equity.
- Peer context: While SAR experienced a sharper decline than many peers, its performance remains within the volatility typical of the sector during a broader market correction.
Investors should monitor the upcoming AGM outcomes and assess how the proposed remuneration and capital‑raising measures may influence Saratoga Investment Corp.’s long‑term shareholder value.
